Patient characteristics
. | Data . |
|---|---|
| No. patients | 38 |
| No. men/no. women | 18/20 |
| Age, median y (range) | 62 (21-87) |
| Subtype, no. | |
| Acute | 23 |
| Chronic | 12 |
| Smoldering | 3 |
| WBC, median × 109/L (range) | 8.4 (1.5-47.94) |
| Abnormal lymphocytes, median % (range) | 15 (1-78) |
| LDH, median IU/L (range) | 561 (204-4141) |
| Hypercalcemia, no. | |
| No | 33 |
| Yes | 5 |
| PS, no. | |
| 0 | 17 |
| 1 | 8 |
| 2 | 6 |
| 3 | 3 |
| 4 | 4 |
| Response to chemotherapy, no. | |
| PR | 14 |
| CR | 2 |
| PD | 7 |
. | Data . |
|---|---|
| No. patients | 38 |
| No. men/no. women | 18/20 |
| Age, median y (range) | 62 (21-87) |
| Subtype, no. | |
| Acute | 23 |
| Chronic | 12 |
| Smoldering | 3 |
| WBC, median × 109/L (range) | 8.4 (1.5-47.94) |
| Abnormal lymphocytes, median % (range) | 15 (1-78) |
| LDH, median IU/L (range) | 561 (204-4141) |
| Hypercalcemia, no. | |
| No | 33 |
| Yes | 5 |
| PS, no. | |
| 0 | 17 |
| 1 | 8 |
| 2 | 6 |
| 3 | 3 |
| 4 | 4 |
| Response to chemotherapy, no. | |
| PR | 14 |
| CR | 2 |
| PD | 7 |
LDH indicates lactose dehydrogenase; PR, partial response; CR, complete response; and PD, progressive disease.